Biotin (Vitamin H or B7)

Micronutrients: Sources, Properties and Health Effects

Volumn , Issue , 2012, Pages 65-93

  Polyak, Steven W ^a   Bailey, Lisa M ^b   Azhar, Al ^a   Booker, Grant W ^a  

^a Rundle Mall   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891144483     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (182)

1. Kogl F, Tonnis B. Über das Bios-problem. Darstellung von krystallisiertem Biotin aus Eigelb. Z. Physiol. Chem. 1936;242:43-73.
2. Steinitz F. Ueber das Verhalten phosphorhaltiger Eiweisskorper im Stoffwechsel. Arch. Gesamte. Physiol. 1898;72:75.
3. du Vigneaud V, Melville DB, Gyorgy P, Rose CS. On the identity of vitamin H with biotin. Science. 1940;92:62-3.
4. Gyorgy P, Rose CS, Hofmann K, Melville DB, du Vigneaud V. A further note on the identity of vitamin H with biotin. Science. 1940;92:609.
5. Eakin RE, Snell EE, Williams RJ. J. Biol. Chem. 1941;140:535.
6. du Vigneaud V, Melville DB, Folkers K, Wolf DE, Mozingo R. The structure of biotin: A study of desthiobiotin. J. Biol. Chem. 1942;146:475-85.
7. Harris SA, Wolf DE, Mozingo R, Folkers K. Synthetic biotin. Science. 1943;97:447-48.
8. Traub W. Crystal structure of biotin. Nature. 1956;178:649.
9. Lynen F, Knappe J, Lorch E, Jutting G, Ringelmann E. The biochemical function of biotin. Angew Chem. 1959;71(481):482-6.
10. Kosow DP, Huang SC, Lane MD. Propionyl holocarboxylase synthesis. J. Biol. Chem. 1962;237:3633.
11. Wolf DE, Valiant J, Peck RL, Folkers K. Synthesis of biocytin. J. Am. Chem. Soc. 1952;74:2002-3.
12. Samols D, Thornton CG, Murtif VL, Kumar GK, Haase FC, Wood HG. Evolutionary conservation among biotin enzymes. J. Biol. Chem. 1988;263:6461-4.
13. Visser CM, Kellogg RM. Biotin. Its place in evolution. Mol. Evol. 1978;11:171-87.
14. Lane MD. The biotin connection: Severo Ochoa, Harland Wood, and Feodor Lynen. J. Biol. Chem. 2004;279(38):39187-94.
15. Ames BN, Elson-Schwab I, Silver EA. High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased K(m)): relevance to genetic disease and polymorphisms. Am J. Clin. Nutr. 2002;75(4):616-58.
16. Zempleni J, Mock DM. Biotin biochemistry and human requirements. J. Nutr. Biochem. 1999;10(3):128-38.
17. Teran-Garcia M, Ibarra I, Velazquez A. Urinary organic acids in infant malnutrition. Pediatr. Res. 1998;44(3):386-91.
18. Velazquez A, Martin-del-Campo C, Baez A, Zamudio S, Quiterio M, Aguilar JL, et al. Biotin deficiency in protein-energy malnutrition. Eur. J. Clin. Nutr. 1989;43(3):169-73.
19. Polyak SW, Chapman-Smith A. Biotin. In: Lennarz WJ, Lane MD, editors. Encyclopedia of Biological Chemistry. Oxford: Elsevier; 2004. p. 174-8.
20. Attwood PV, Wallace JC. Chemical and catalytic mechanisms of carboxyl transfer reactions in biotin-dependent enzymes. Acc. Chem. Res. 2002;35(2):113-20.
21. Carey PR, Sonnichsen FD, Yee VC. Transcarboxylase: one of nature's early nanomachines. IUBMB Life. 2004;56(10):575-83.
22. Abu-Elheiga L, Brinkley WR, Zhong L, Chirala SS, Woldegiorgis G, Wakil SJ. The subcellular localization of acetyl-CoA carboxylase 2. Proc. Natl. Acad. Sci. USA. 2000;97(4):1444-9.
23. Abu-Elheiga L, Matzuk MM, Abo-Hashema KA, Wakil SJ. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science. 2001;291(5513):2613-6.
24. Abu-Elheiga L, Matzuk MM, Kordari P, Oh W, Shaikenov T, Gu Z, et al. Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal. Proc. Natl. Acad. Sci. USA. 2005;102(34):12011-6.
25. Kim KH. Regulation of mammalian acetyl-coenzyme A carboxylase. Annu. Rev. Nutr. 1997;17:77-99.
26. Jitrapakdee S, St Maurice M, Rayment I, Cleland WW, Wallace JC, Attwood PV. Structure, mechanism and regulation of pyruvate carboxylase. Biochemical J. 2008;413(3):369-87.
27. Baumgartner MR. Molecular mechanism of dominant expression in 3-methylcrotonyl-CoA carboxylase deficiency. J. Inherit. Metab. Dis. 2005;28(3):301-9.
28. Mock NI, Malik MI, Stumbo PJ, Bishop WP, Mock DM. Increased urinary excretion of 3-hydroxyisovaleric acid and decreased urinary excretion of biotin are sensitive early indicators of decreased biotin status in experimental biotin deficiency. Am. J. Clin. Nutr. 1997;65(4):951-8.
29. Baumgartner ER, Suormala T. Multiple carboxylase deficiency - Inherited and acquired disorders of Biotin metabolism. Int. J. Vit. Nutr. Res. 1997;67(5):377-84.
30. Wolf B, Hsia YE, Sweetman L, Feldman G, Boychuk RB, Bart RD, et al. Multiple carboxylase deficiency: clinical and biochemical improvement following neonatal biotin treatment. Pediatrics. 1981;68(1):113-8.
31. Lane MD, Rominger KL, Young DL, Lynen F. The enzymatic synthesis of holotranscarboxylase from apotranscarboxylase and (+)-biotin. J. Biol. Chem. 1964;239(9):2865-71.
32. Xu Y, Beckett D. Kinetics of biotinyl-5'-adenylate synthesis catalyzed by the Escherichia coli repressor of biotin biosynthesis and the stability of the enzyme-product complex. Biochemistry. 1994;33(23):7354-60.
33. Bagautdinov B, Kuroishi C, Sugahara M, Kunishima N. Crystal structures of biotin protein ligase from Pyrococcus horikoshii OT3 and its complexes: structural basis of biotin activation. J. Mol. Biol. 2005;353(2):322-33.
34. Bagautdinov B, Matsuura Y, Bagautdinova S, Kunishima N. Protein biotinylation visualized by a complex structure of biotin protein ligase with a substrate. J. Biol. Chem. 2008;283(21):14739-50.
35. Wilson KP, Shewchuk LM, Brennan RG, Otsuka AJ, Matthews BW. Escherichia coli biotin holoenzyme synthetase/bio repressor crystal structure delineates the biotin- and DNA-binding domains. Proc. Natl. Acad. Sci. USA. 1992;89:9257-61.
36. Reche PA. Lipoylating and biotinylating enzymes contain a homologous catalytic module. Protein. Sci. 2000;9(10):1922-9.
37. Beckett D. Biotin sensing at the molecular level. J. Nutr. 2009;139(1):167-70.
38. Pendini NR, Bailey LM, Booker GW, Wilce MC, Wallace JC, Polyak SW. Microbial biotin protein ligases aid in understanding holocarboxylase synthetase deficiency. Biochim. Biophys. Acta. 2008;1784(7-8):973-82.
39. Tron CM, McNae IW, Nutley M, Clarke DJ, Cooper A, Walkinshaw MD, et al. Structural and functional studies of the biotin protein ligase from Aquifex aeolicus reveal a critical role for a conserved residue in target specificity. J. Mol. Biol. 2009;387(1):129-46.
40. St Maurice M, Reinhardt L, Surinya KH, Attwood PV, Wallace JC, Cleland WW, et al. Domain architecture of pyruvate carboxylase, a biotin-dependent multifunctional enzyme. Science. 2007;317 (5841):1076-9.
41. Xiang S, Tong L. Crystal structures of human and Staphylococcus aureus pyruvate carboxylase and molecular insights into the carboxyltransfer reaction. Nat. Struct. Mol. Biol. 2008;15(3):295-302.
42. Huang CS, Sadre-Bazzaz K, Shen Y, Deng B, Zhou ZH, Tong L. Crystal structure of the alpha(6)beta(6) holoenzyme of propionyl-coenzyme A carboxylase. Nature. 2010;466(7309):1001-5.
43. Cronan JE, Jr. Biotination of proteins in vivo. A post-translational modification to label, purify, and study proteins. J. Biol. Chem. 1990;265(18):10327-33.
44. Leon-Del-Rio A, Leclerc D, Akerman B, Wakamatsu N, Gravel RA. Isolation of a cDNA encoding human holocarboxylase synthetase by functional complementation of a biotin auxotroph of Escherichia coli. Proc. Natl. Acad. Sci. USA. 1995;92(10):4626-30.
45. McAllister HC, Coon MJ. Further studies on the properties of liver propionyl coenzyme A holoenzyme synthetase and the specificity of holocarboxylase formation. J. Biol. Chem. 1966;241:2855-61.
46. Murtif VL, Samols D. Mutagenesis affecting the carboxyl terminu of the biotinyl subunit of transcarboxylase. J. Biol. Chem. 1987;262:11813-6.
47. Polyak SW, Chapman-Smith A, Mulhern TD, Cronan JE, Jr., Wallace JC. Mutational analysis of protein substrate presentation in the post-translational attachment of biotin to biotin domains. J. Biol. Chem. 2001;276(5):3037-45.
48. Reed KE, Cronan JEJ. Escherichia coli exports previously folded and biotinated protein domains. J. Biol. Chem. 1991;266(18):11425-8.
49. Athappilly FK, Hendrickson WA. Structure of the biotinyl domain of acetyl-coenzyme A carboxylase determined by MAD phasing. Structure. 1995;3(12):1407-19.
50. Cronan JE, Jr. The biotinyl domain of Escherichia coli acetyl-CoA carboxylase. Evidence that the "thumb" structure is essential and that the domain functions as a dimer. J. Biol. Chem. 2001;276(40):37355-64.
51. Reche P, Perham RN. Structure and selectivity in post-translational modification: attaching the biotinyl-lysine and lipoyl-lysine swinging arms in multifunctional enzymes. EMBO. J. 1999;18:2673-82.
52. Healy S, McDonald MK, Wu X, Yue WW, Kochan G, Oppermann U, et al. Structural impact of human and Escherichia coli biotin carboxyl carrier proteins on biotin attachment. Biochemistry. 2010;49(22):4687-94.
53. Suzuki Y, Aoki Y, Ishida Y, Chiba Y, Iwamatsu A, Kishino T, et al. Isolation and characterization of mutations in the human holocarboxylase synthetase cDNA. Nat. Genet. 1994;8(2):122-8.
54. Feldman GL, Wolf B. Deficient acetyl CoA carboxylase activity in multiple carboxylase deficiency. Clin. Chim. Acta. 1981;111(2-3):147-51.
55. Campeau E, Gravel RA. Expression in Escherichia coli of N- and C-terminally deleted human holocarboxylase synthetase. Influence of the N-terminus on biotinylation and identification of a minimum functional protein. J. Biol. Chem. 2001;276(15):12310-6.
56. Lee CK, Cheong C, Jeon YH. The N-terminal domain of human holocarboxylase synthetase facilitates biotinylation via direct interaction with the substrate protein. FEBS Lett. 2010;584(4):675-80.
57. Suzuki Y, Yang X, Aoki Y, Kure S, Matsubara Y. Mutations in the holocarboxylase synthetase gene HLCS. Hum. Mutat. 2005;26(4):285-90.
58. Aoki Y, Suzuki Y, Li X, Sakamoto O, Chikaoka H, Takita S, et al. Characterization of mutant Holocarboxylase synthetase (HCS) - a KM for biotin was not elevated in a patient with HCS deficiency. Ped. Res. 1997;42(6):849-54.
59. Santer R, Muhle H, Suormala T, Baumgartner ER, Duran M, Yang X, et al. Partial response to biotin therapy in a patient with holocarboxylase synthetase deficiency: clinical, biochemical, and molecular genetic aspects. Mol. Genet. Metab. 2003;79(3):160-6.
60. Wilson CJ, Myer M, Darlow BA, Stanley T, Thomson G, Baumgartner ER, et al. Severe holocarboxylase synthetase deficiency with incomplete biotin responsiveness resulting in antenatal insult in samoan neonates. J. Pediatr. 2005;147(1):115-8.
61. Bailey LM, Ivanov RA, Jitrapakdee S, Wilson CJ, Wallace JC, Polyak SW. Reduced half-life of holocarboxylase synthetase from patients with severe multiple carboxylase deficiency. Hum. Mutat. 2008;29(6):E47-57.
62. Mayende L, Swift RD, Bailey LM, Soares da Costa TP, Wallace JC, Booker GW, et al. A novel molecular mechanism to explain biotin-unresponsive Holocarboxylase synthetase deficiency. J. Mol. Med. 2011; Sep 6 [Epub ahead of print].
63. Wolf B. Clinical issues and frequent questions about biotinidase deficiency. Mol. Genet. Metab. 2010;100(1):6-13.
64. Wolf B, Grier RE, Secor McVoy JR, Heard GS. Biotinidase deficiency: a novel vitamin recycling defect. J. Inherit. Metab. Dis. 1985;8 Suppl 1:53-8.
65. Bowman BB, Rosenberg IH. Biotin absorption by distal rat intestine. J. Nutr. 1987;117(12):2121-6.
66. Grier RE, Heard GS, Watkins P, Wolf B. Low biotinidase activities in the sera of patients with impaired liver function: evidence that the liver is the source of serum biotinidase. Clin. Chim. Acta. 1990;186(3):397-400.
67. Cole H, Reynolds TR, Lockyer JM, Buck GA, Denson T, Spence JE, et al. Human serum biotinidase. cDNA cloning, sequence, and characterization. J. Biol. Chem. 1994;269(9):6566-70.
68. Heard GS, Wolf B, Jefferson LG, Weissbecker KA, Nance WE, McVoy JR, et al. Neonatal screening for biotinidase deficiency: results of a 1-year pilot study. J. Pediatr. 1986;108(1):40-6.
69. Norrgard KJ, Hymes J, Wolf B. Examination of the signal peptide region of human biotinidase using a baculovirus expression system. Mol. Genet. Metab. 2000;69(1):56-63.
70. Hart PS, Hymes J, Wolf B. Isoforms of human serum biotinidase. Clin. Chim. Acta. 1991;197(3):257-64.
71. Pindolia K, Jensen K, Wolf B. Three dimensional structure of human biotinidase: computer modeling and functional correlations. Mol .Genet. Metab. 2007;92(1-2):13-22.
72. Pindolia K, Jordan M, Wolf B. Analysis of mutations causing biotinidase deficiency. Hum. Mutat. 2010;31(9):983-91.
73. Salbert BA, Pellock JM, Wolf B. Characterization of seizures associated with biotinidase deficiency. Neurology. 1993;43(7):1351-5.
74. Heard GS, Secor McVoy JR, Wolf B. A screening method for biotinidase deficiency in newborns. Clin. Chem. 1984;30(1):125-7.
75. Kaye CI, Accurso F, La Franchi S, Lane PA, Northrup H, Pang S, et al. Introduction to the newborn screening fact sheets. Pediatrics. 2006;118(3):1304-12.
76. Wolf B. Worldwide survey of neonatal screening for biotinidase deficiency. J. Inherit. Metab. Dis. 1991;14(6):923-7.
77. Schulpis KH, Karikas GA, Tjamouranis J, Regoutas S, Tsakiris S. Low serum biotinidase activity in children with valproic acid monotherapy. Epilepsia. 2001;42(10):1359-62.
78. Yilmaz Y, Tasdemir HA, Paksu MS. The influence of valproic acid treatment on hair and serum zinc levels and serum biotinidase activity. Eur. J. Paediatr. Neurol. 2009;13(5):439-43.
79. Castro-Gago M, Gomez-Lado C, Eiris-Punal J, Diaz-Mayo I, Castineiras-Ramos DE. Serum biotinidase activity in children treated with valproic acid and carbamazepine. J. Child. Neurol. 2010;25(1):32-5.
80. Castro-Gago M, Perez-Gay L, Gomez-Lado C, Castineiras-Ramos DE, Otero-Martinez S, Rodriguez-Segade S. The Influence of Valproic Acid and Carbamazepine Treatment on Serum Biotin and Zinc Levels and on Biotinidase Activity. J. Child Neurol. 2011. in press.
81. Said HM. Cell and molecular aspects of human intestinal biotin absorption. J. Nutr. 2009;139(1):158-62.
82. Baumgartner ER, Suormala T, Wick H, Bausch J, Bonjour JP. Biotinidase deficiency associated with renal loss of biocytin and biotin. Ann. NY Acad. Sci. 1985;447:272-87.
83. Suormala T, Wick H, Bonjour JP, Baumgartner ER. Intestinal absorption and renal excretion of biotin in patients with biotinidase deficiency. Eur. J. Pediatr. 1985;144(1):21-6.
84. Dyer DL, Said HM. Biotin uptake in cultured cell lines. Methods Enzmol. 1997;279:393-405.
85. Shi F, Bailey C, Malick AW, Audus KL. Biotin uptake and transport across bovine brain microvessel endothelial cell monolayers. Pharm. Res. 1993;10(2):282-8.
86. Weiner D, Wolf B. Biotin uptake, utilization, and efflux in normal and biotin-deficient rat hepatocytes. Biochem. Med. Metab. Biol. 1991;46(3):344-63.
87. Prasad PD, Ramamoorthy S, Leibach FH, Ganapathy V. Characterization of a sodiumdependent vitamin transporter mediating the uptake of pantothenate, biotin and lipoate in human placental choriocarcinoma cells. Placenta. 1997;18(7):527-33.
88. Said HM, Redha R, Nylander W. Biotin transport in basolateral membrane vesicles of human intestine. Gastroenterology. 1988;94(5 Pt 1):1157-63.
89. Said HM, Redha R, Nylander W. A carrier-mediated, Na+ gradient-dependent transport for biotin in human intestinal brush-border membrane vesicles. Am. J. Physiol. 1987;253(5 Pt 1):G631-6.
90. Subramanian VS, Marchant JS, Boulware MJ, Ma TY, Said HM. Membrane targeting and intracellular trafficking of the human sodium-dependent multivitamin transporter in polarized epithelial cells. Am. J. Physiol. Cell Physiol. 2009;296(4):C663-71.
91. Park S, Sinko PJ. The blood-brain barrier sodium-dependent multivitamin transporter: a molecular functional in vitro-in situ correlation. Drug Metab. Dispos. 2005;33(10):1547-54.
92. Ohkura Y, Akanuma S, Tachikawa M, Hosoya K. Blood-to-retina transport of biotin via Na+-dependent multivitamin transporter (SMVT) at the inner blood-retinal barrier. Exp. Eye Res. 2010;91(3):387-92.
93. Wang H, Huang W, Fei YJ, Xia H, Yang-Feng TL, Leibach FH, et al. Human placental Na+-dependent multivitamin transporter. Cloning, functional expression, gene structure, and chromosomal localization. J. Biol. Chem. 1999;274(21):14875-83.
94. Prasad PD, Wang H, Huang W, Fei YJ, Leibach FH, Devoe LD, et al. Molecular and functional characterization of the intestinal Na+-dependent multivitamin transporter. Arch. Biochem. Biophys. 1999;366(1):95-106.
95. Ghosal A, Said HM. Structure-function activity of the human sodium-dependent multivitamin transporter: role of Hisand#185; and#185;and#8309; and His(2). Am. J. Physiol. Cell Physiol. 2011;300(1):C97-104.
96. Ghosal A, Subramanian VS, Said HM. Role of the putative N-glycosylation and PKCphosphorylation sites of the human sodium-dependent multivitamin transporter (hSMVT) in function and regulation. Biochim. Biophys. Acta. 2011;1808(8):2073-80.
97. Said HM, Ortiz A, McCloud E, Dyer D, Moyer MP, Rubin S. Biotin uptake by human colonic epithelial NCM460 cells: a carrier-mediated process shared with pantothenic acid. Am. J. Physiol. 1998;275(5 Pt 1):C1365-71.
98. Said HM. Cellular uptake of biotin: Mechanisms and regulation. J. Nutr. 1999;129:490S-3S.
99. Pacheco-Alvarez D, Solorzano-Vargas RS, Gonzalez-Noriega A, Michalak C, Zempleni J, Leon-Del-Rio A. Biotin availability regulates expression of the sodiumdependent multivitamin transporter and the rate of biotin uptake in HepG2 cells. Mol. Genet. Metabol. 2005;85(4):301-7.
100. Manthey KC, Griffin JB, Zempleni J. Biotin supply affects expression of biotin transporters, biotinylation of carboxylases and metabolism of interleukin-2 in Jurkat cells. J. Nutr. 2002;132(5):887-92.
101. Baur B, Suormala T, Baumgartner ER. Biocytin and biotin uptake into NB2a neuroblastoma and C6 astrocytoma cells. Brain. Res. 2002;925(2):111-21.
102. Daberkow RL, White BR, Cederberg RA, Griffin JB, Zempleni J. Monocarboxylate transporter 1 mediates biotin uptake in human peripheral blood mononuclear cells. J. Nutr. 2003;133(9):2703-6.
103. Grafe F, Wohlrab W, Neubert RH, Brandsch M. Transport of biotin in human keratinocytes. J. Invest. Dermatol. 2003;120(3):428-33.
104. Zempleni J, Mock DM. Uptake and metabolism of biotin by human peripheral blood mononuclear cells. Am. J. Physiol. 1998;275(2 Pt 1):C382-8.
105. Mardach R, Zempleni J, Wolf B, Cannon MJ, Jennings ML, Cress S, et al. Biotin dependency due to a defect in biotin transport. J. Clin. Invest. 2002;109(12):1617-23.
106. Said HM, Sharifian A, Bagherzadeh A, Mock D. Chronic ethanol feeding and acute ethanol exposure in vitro: effect on intestinal transport of biotin. Am. J. Clin. Nutr. 1990;52(6):1083-6.
107. Subramanya SB, Subramanian VS, Kumar JS, Hoiness R, Said HM. Inhibition of intestinal biotin absorption by chronic alcohol feeding: cellular and molecular mechanisms. Am. J. Physiol. Gastrointest Liver. Physiol. 2011;300(3):G494-501.
108. Fennelly J, Frank O, Baker H, Leevy CM. Peripheral Neuropathy of the Alcoholic: I, Aetiological Role of Aneurin and Other B-Complex Vitamins. Br. Med. J. 1964;2(5420):1290-2.
109. Bonjour JP. Vitamins and alcoholism. V. Riboflavin, VI. Niacin, VII. Pantothenic acid, and VIII. Biotin. Int. J. Vitam. Nutr. Res. 1980;50(4):425-40.
110. Subramanian VS, Subramanya SB, Said HM. Chronic alcohol exposure negatively impacts the physiological and molecular parameters of the renal biotin reabsorption process. Am. J. Physiol. Renal. Physiol. 2011;300(3):F611-7.
111. Subramanya SB, Subramanian VS, Said HM. Chronic alcohol consumption and intestinal thiamin absorption: effects on physiological and molecular parameters of the uptake process. Am. J. Physiol. Gastrointest Liver Physiol. 2010;299(1):G23-31.
112. Subramanian VS, Subramanya SB, Tsukamoto H, Said HM. Effect of chronic alcohol feeding on physiological and molecular parameters of renal thiamin transport. Am. J. Physiol. Renal. Physiol. 2010;299(1):F28-34.
113. Said HM, Mee L, Sekar VT, Ashokkumar B, Pandol SJ. Mechanism and regulation of folate uptake by pancreatic acinar cells: effect of chronic alcohol consumption. Am. J. Physiol. Gastrointest Liver Physiol. 2010;298(6):G985-93.
114. Said HM, Redha R, Nylander W. Biotin transport in the human intestine: inhibition by anticonvulsant drugs. Am. J. Clin. Nutr. 1989;49(1):127-31.
115. Mock DM, Mock NI, Nelson RP, Lombard KA. Disturbances in biotin metabolism in children undergoing long-term anticonvulsant therapy. J. Pediatr. Gastroenterol. Nutr. 1998;26(3):245-50.
116. Krause KH, Berlit P, Bonjour JP. Impaired biotin status in anticonvulsant therapy. Ann. Neurol. 1982;12(5):485-6.
117. Krause KH, Bonjour JP, Berlit P, Kochen W. Biotin status of epileptics. Ann. NY Acad. Sci. 1985;447:297-313.
118. Dakshinamurti K, Mistry SP. Tissue and intracellular distribution of biotin-C-1400H in rats and chicks. J. Biol. Chem. 1963;238:294-6.
119. Wiedmann S, Eudy JD, Zempleni J. Biotin supplementation increases expression of genes encoding interferon-gamma, interleukin-1beta, and 3-methylcrotonyl-CoA carboxylase, and decreases expression of the gene encoding interleukin-4 in human peripheral blood mononuclear cells. J. Nutr. 2003;133(3):716-9.
120. Rodriguez-Melendez R, Camporeale G, Griffin JB, Zempleni J. Interleukin-2 receptorgamma -dependent endocytosis depends on biotin in Jurkat cells. Am. J. Physiol. Cell Physiol. 2003;284(2):C415-21.
121. Rodriguez-Melendez R, Cano S, Mendez ST, Velazquez A. Biotin regulates the genetic expression of holocarboxylase synthetase and mitochondrial carboxylases in rats. J. Nutr. 2001;131(7):1909-13.
122. Spence JT, Koudelka AP. Effects of biotin upon the intracellular level of cGMP and the activity of glucokinase in cultured rat hepatocytes. J. Biol. Chem. 1984;259(10):6393-6.
123. Chauhan J, Dakshinamurti K. Transcriptional regulation of the glucokinase gene by biotin in starved rats. J. Biol. Chem. 1991;266(16):10035-8.
124. Romero-Navarro G, Cabrera-Valladares G, German MS, Matschinsky FM, Velazquez A, Wang J, et al. Biotin regulation of pancreatic glucokinase and insulin in primary cultured rat islets and in biotin-deficient rats. Endocrinology. 1999;140(10):4595-600.
125. Cherbonnel-Lasserre CL, Linares-Cruz G, Rigaut JP, Sabatier L, Dutrillaux B. Strong decrease in biotin content may correlate with metabolic alterations in colorectal adenocarcinoma. Int. J. Cancer. 1997;72(5):768-75.
126. Solorzano-Vargas RS, Pacheco-Alvarez D, Leon-Del-Rio A. Holocarboxylase synthetase is an obligate participant in biotin-mediated regulation of its own expression and of biotin-dependent carboxylases mRNA levels in human cells. Proc. Natl. Acad. Sci. USA. 2002;99(8):5325-30.
127. Gudi T, Huvar I, Meinecke M, Lohmann SM, Boss GR, Pilz RB. Regulation of gene expression by cGMP-dependent protein kinase. Transactivation of the c-fos promoter. J. Biol. Chem. 1996;271(9):4597-600.
128. Collins JC, Paietta E, Green R, Morell AG, Stockert RJ. Biotin-dependent expression of the asialoglycoprotein receptor in HepG2. J. Biol. Chem. 1988;263(23):11280-3.
129. Stockert RJ, Ren Q. Cytoplasmic protein mRNA interaction mediates cGMP-modulated translational control of the asialoglycoprotein receptor. J. Biol. Chem. 1997;272(14):9161-5.
130. Hymes J, Fleischhauer K, Wolf B. Biotinylation of histones by human serum biotinidase: assessment of biotinyl-transferase activity in sera from normal individuals and children with biotinidase deficiency. Biochem. Mol. Med. 1995;56(1):76-83.
131. Hassan YI, Zempleni J. A novel, enigmatic histone modification: biotinylation of histones by holocarboxylase synthetase. Nutrition. Reviews. 2008;66(12):721-5.
132. Rodriguez-Melendez R, Zempleni J. Regulation of gene expression by biotin (review). J. Nutr. Biochem. 2003;14(12):680-90.
133. Berger SL. Histone modifications in transcriptional regulation. Curr Opin. Genet. Dev. 2002;12(2):142-8.
134. Hymes J, Wolf B. Human biotinidase isn't just for recycling biotin. J. Nutr. 1999;129:485S-9S.
135. Ballard TD, Wolff J, Griffin JB, Stanley JS, van Calcar S, Zempleni J. Biotinidase catalyzes debiotinylation of histones. Eur. J. Nutr. 2002;41(2):78-84.
136. Stanley JS, Griffin JB, Zempleni J. Biotinylation of histones in human cells. Effects of cell proliferation. Eur. J. Biochem. 2001;268(20):5424-9.
137. Bailey LM, Wallace JC, Polyak SW. Holocarboxylase synthetase: correlation of protein localisation with biological function. Arch. Biochem. Biophys. 2010;496(1):45-52.
138. Narang MA, Dumas R, Ayer LM, Gravel RA. Reduced histone biotinylation in multiple carboxylase deficiency patients: a nuclear role for holocarboxylase synthetase. Hum. Mol. Genet. 2004;13(1):15-23.
139. Healy S, Heightman TD, Hohmann L, Schriemer D, Gravel RA. Nonenzymatic biotinylation of histone H2A. Protein. Sci. 2009;18(2):314-28.
140. Bailey LM, Ivanov RA, Wallace JC, Polyak SW. Artifactual detection of biotin on histones by streptavidin. Anal. Biochem. 2008;373(1):71-7.
141. Healy S, Perez-Cadahia B, Jia D, McDonald MK, Davie JR, Gravel RA. Biotin is not a natural histone modification. Biochim. Biophys. Acta. 2009;1789(11-12):719-33.
142. Mock DM, Stadler DD. Conflicting indicators of biotin status from a cross-sectional study of normal pregnancy. J. Am. Coll. Nutr. 1997;16(3):252-7.
143. Mock DM, Stadler DD, Stratton SL, Mock NI. Biotin status assessed longitudinally in pregnant women. J. Nutr. 1997;127(5):710-6.
144. Mock DM, Quirk JG, Mock NI. Marginal biotin deficiency during normal pregnancy. Am. J. Clin. Nutr. 2002;75(2):295-9.
145. Diaz SO, Pinto J, Graca G, Duarte IF, Barros AS, Galhano E, et al. Metabolic Biomarkers of Prenatal Disorders: An Exploratory NMR Metabonomics Study of Second Trimester Maternal Urine and Blood Plasma. J. Proteome. Res. 2011. in press.
146. Organisation WH. WHO Factsheet on Obesity and Overweight. 2011.
147. Callaway LK, Prins JB, Chang AM, McIntyre HD. The prevalence and impact of overweight and obesity in an Australian obstetric population. Med. J. Aust. 2006;184(2):56-9.
148. Zempleni J, Mock DM. Marginal biotin deficiency is teratogenic. Proc.. Soc. Exp. Bio.l Med. 2000;223(1):14-21.
149. Mock DM, Mock NI, Stewart CW, LaBorde JB, Hansen DK. Marginal biotin deficiency is teratogenic in ICR mice. J. Nutr. 2003;133(8):2519-25.
150. Watanabe T. Teratogenic effects of biotin deficiency in mice. J. Nutr. 1983;113(3):574-81.
151. Watanabe T, Endo A. Teratogenic effects of avidin-induced biotin deficiency in mice. Teratology. 1984;30:91-4.
152. Maebashi M, Makino Y, Furukawa Y, Ohinata K, Kimura S, Sato K. Therapeutic evaulation of the effect of biotin on hypergylcemia in patients with non-insulin dependent diabetes mellitus. J. Clin. Biochem. Nutr. 1993;14:211-8.
153. Coggeshall JC, Heggers JP, Robson MC, Baker H. Biotin status and plasma glucose levels in diabetics Ann. NY Acad. Sci. 1985;447:389-92.
154. Baez-Saldana A, Zendejas-Ruiz I, Revilla-Monsalve C, Islas-Andrade S, Cardenas A, Rojas-Ochoa A, et al. Effects of biotin on pyruvate carboxylase, acetyl-CoA carboxylase, propionyl-CoA carboxylase, and markers for glucose and lipid homeostasis in type 2 diabetic patients and nondiabetic subjects. Am. J. Clin. Nutr. 2004;79(2):238-43.
155. Revilla-Monsalve C, Zendejas-Ruiz I, Islas-Andrade S, Baez-Saldana A, Palomino-Garibay MA, Hernandez-Quiroz PM, et al. Biotin supplementation reduces plasma triacylglycerol and VLDL in type 2 diabetic patients and in nondiabetic subjects with hypertriglyceridemia. Biomed. Pharmacother. 2006;60(4):182-5.
156. Marshall MW, Kliman PG, Washington VA, Mackin JF, Weinland BT. Effects of biotin on lipids and other constituents of plasma of healthy men and women. Artery. 1980;7(4):330-51.
157. Albarracin CA, Fuqua BC, Evans JL, Goldfine ID. Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes. Diabetes. Metab. Res. Rev. 2008;24(1):41-51.
158. Shen W, Hao J, Tian C, Ren J, Yang L, Li X, et al. A combination of nutriments improves mitochondrial biogenesis and function in skeletal muscle of type 2 diabetic Goto-Kakizaki rats. PLoS One. 2008;3(6):e2328.
159. Farvid MS, Homayouni F, Amiri Z, Adelmanesh F. Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation. Diabetes. Res. Clin. Pract. 2011. in press.
160. Dakshinamurti K, Li W. Transcriptional regulation of liver phosphoenolpyruvate carboxykinase by biotin in diabetic rats. Mol. Cell Biochem. 1994;132(2):127-32.
161. Jen M, Yan AC. Syndromes associated with nutritional deficiency and excess. Clin. Dermatol. 2010;28(6):669-85.
162. Gehrig KA, Dinulos JG. Acrodermatitis due to nutritional deficiency. Curr. Opin. Pediatr. 2010;22(1):107-12.
163. Hochman LG, Scher RK, Meyerson MS. Brittle nails: response to daily biotin supplementation. Cutis. 1993;51(4):303-5.
164. Reilly JD, Cottrell DF, Martin RJ, Cuddeford DJ. Effect of supplementary dietary biotin on hoof growth and hoof growth rate in ponies: a controlled trial. Equine. Vet. J. Suppl. 1998(26):51-7.
165. Colombo VE, Gerber F, Bronhofer M, Floersheim GL. Treatment of brittle fingernails and onychoschizia with biotin: scanning electron microscopy. J. Am. Acad. Dermatol. 1990;23(6 Pt 1):1127-32.
166. Mock DM, Heird GM. Urinary biotin analogs increase in humans during chronic supplementation: the analogs are biotin metabolites. Am. J. Physiol. 1997;272(1 Pt 1):E83-5.
167. Arslan M, Vurucu S, Balamtekin N, Unay B, Akin R, Kurt I, et al. The effects of biotin supplementation on serum and liver tissue biotinidase enzyme activity and alopecia in rats which were administrated to valproic acid. Brain. Dev. 2009;31(6):405-10.
168. Sealey WM, Teague AM, Stratton SL, Mock DM. Smoking accelerates biotin catabolism in women. Am. J. Clin. Nutr. 2004;80(4):932-5.
169. Fischer A, Munnich A, Saudubray JM, Mamas S, Coude FX, Charpentier C, et al. Biotin-responsive immunoregulatory dysfunction in multiple carboxylase deficiency. J. Clin. Immunol. 1982;2(1):35-8.
170. Wiedmann S, Rodriguez-Melendez R, Ortega-Cuellar D, Zempleni J. Clusters of biotinresponsive genes in human peripheral blood mononuclear cells. J. Nutr. Biochem. 2004;15(7):433-9.
171. Kuroishi T, Endo Y, Muramoto K, Sugawara S. Biotin deficiency up-regulates TNFalpha production in murine macrophages. J. Leukoc. Biol. 2008;83(4):912-20.
172. Kuroishi T, Kinbara M, Sato N, Tanaka Y, Nagai Y, Iwakura Y, et al. Biotin status affects nickel allergy via regulation of interleukin-1beta production in mice. J. Nutr. 2009;139(5):1031-6.
173. Baez-Saldana A, Ortega E. Biotin deficiency blocks thymocyte maturation, accelerates thymus involution, and decreases nose-rump length in mice. J. Nutr. 2004;134(8):1970-7.
174. Baez-Saldana A, Diaz G, Espinoza B, Ortega E. Biotin deficiency induces changes in subpopulations of spleen lymphocytes in mice. Am. J. Clin. Nutr. 1998;67(3):431-7.
175. Shannon-Lowe J, Matheson NJ, Cooke FJ, Aliyu SH. Prevention and medical management of Clostridium difficile infection. BMJ. 2010;340:c1296.
176. Karlsson S, Burman LG, Akerlund T. Suppression of toxin production in Clostridium difficile VPI 10463 by amino acids. Microbiology. 1999;145(7):1683-93.
177. Dupuy B, Sonenshein AL. Regulated transcription of Clostridium difficile toxin genes. Mol. Microbiol. 1998;27(1):107-20.
178. Karlsson S, Lindberg A, Norin E, Burman LG, Akerlund T. Toxins, butyric acid, and other short-chain fatty acids are coordinately expressed and down-regulated by cysteine in Clostridium difficile. Infect. Immun. 2000;68(10):5881-8.
179. Karlsson S, Dupuy B, Mukherjee K, Norin E, Burman LG, Akerlund T. Expression of Clostridium difficile toxins A and B and their sigma factor TcdD is controlled by temperature. Infect. Immun. 2003;71(4):1784-93.
180. Yamakawa K, Karasawa T, Ikoma S, Nakamura S. Enhancement of Clostridium difficile toxin production in biotin-limited conditions. J. Med. Microbiol. 1996;44(2):111-4.
181. Yamakawa K, Karasawa T, Ohta T, Hayashi H, Nakamura S. Inhibition of enhanced toxin production by Clostridium difficile in biotin-limited conditions. J. Med. Microbiol. 1998;47(9):767-71.
182. Maegawa T, Karasawa T, Ohta T, Wang X, Kato H, Hayashi H, et al. Linkage between toxin production and purine biosynthesis in Clostridium difficile. J. Med. Microbiol. 2002;51(1):34-41.